CIPLA LTD. - Stempeutics receives US process patent for its novel stem cell drug "Stempeucel"
04 Mar 2015
Cipla Ltd has informed BSE regarding a Press Release dated March 04, 2015 titled "Stempeutics receives US process patent for its novel stem cell drug "Stempeucel"".
Source:
BSE India